As a leading global strategy consulting firm, L.E.K. Consulting has helped its clients deliver value-creating growth by addressing key strategic and operational issues. L.E.K. has worked with fitness clients across many strategic issues, including:

• Developing a post-COVID-19 growth strategy for a leading fitness certification provider
• Supporting the sales process for a leading connected fitness company
• Developing a launch strategy for a digital fitness marketplace
• Quantifying the unit whitespace opportunity for a boutique studio fitness concept

In this episode, we will discuss:

• The current state of the fitness landscape
• Fitness market trends
• Fitness investment themes

To provide insights on these topics, we will hear from Alex Evans, Managing Director and Head of the Los Angeles office for L.E.K. Consulting; Jon Weber, Managing Director at L.E.K. Consulting’s Boston office; Geoff McQueen, Managing Director at L.E.K. Consulting’s Los Angeles office; and Anna Ondik, Senior Engagement Manager at L.E.K. Consulting’s Chicago office.

Connect with our experts on LinkedIn:
Alex Evans: https://www.linkedin.com/in/alexevanslek/
Jon Weber: https://www.linkedin.com/in/jonweberlek/
Geoff McQueen: https://www.linkedin.com/in/geoff-mcqueen/
Anna Ondik: https://www.linkedin.com/in/anna-ondik-464a4b13/

Visit L.E.K. Consulting at https://www.lek.com/

Rapid changes in the biopharma industry are making it increasingly difficult to launch new products successfully. Especially challenging are novel treatment modalities such as gene and cell therapy, the increased use of biomarkers, and expanded requirements to demonstrate economic value. In addition, biopharmas must navigate the declining access to physicians, digitalization, intense competition and the need to launch globally to maximize revenues. 

Faced with such challenges, biopharma companies must optimize their product launch planning and execution process to ensure successful launches of strong products, as covered in our previous piece, Key Indicators of a Successful Biopharmaceutical Launch. 

L.E.K. Consulting has identified five key levers for biopharma launch success, which consist of early preparation, structured and flexible planning, organizational alignment, continuous readiness assessment and the right team. 

In this episode, we will discuss: 

·       The key market and product dynamics for a product launch 

·       Critical product launch success factors and an organization’s focus on them 

·       Preparation and planning for a product launch 

·       Organizational alignment and readiness 

To provide insights on these topics, Peter Rosenorn, Managing Director and Partner in L.E.K. Consulting’s Boston office; Sean Dyson, Partner in L.E.K. Consulting’s London office; and Jenny Mackey, Director of the Healthcare Insights Center at L.E.K. Consulting, discuss the Five Essential Factors for a Successful Biopharma Product Launch.

Connect with our experts on LinkedIn:

Peter Rosenorn: https://www.linkedin.com/in/peterrosenorn/ 

Sean Dyson: https://www.linkedin.com/in/dysonsean/ 

Jenny Mackey: https://www.linkedin.com/in/jenny-mackey-2a594a62/ 

Visit L.E.K. Consulting at https://www.lek.com/

As the U.S. moves toward a zero emissions mandate, Cristóbal Colón, Matthew Wayne, Ricardo Olalla Guerra and José Portilla explore this transition’s impact on the automotive aftermarket and the opportunities available to capitalize on battery-electric vehicles (BEVs) before it’s too late. Since California’s executive order in 2021, other states have followed suit in the U.S., Europe just approved the Fit for 55 directive banning internal combustion engine vehicles in 2035, and original equipment manufacturers (OEMs) are beginning to invest in developing new BEV models.
 
You will learn about the many benefits of transitioning to a BEV when you make the switch to a zero-emission electric vehicle.

"You can't be sitting on your laurels, but you do have time to plan and be very deliberate in how you're approaching this."

Cristóbal is a partner and managing director of L.E.K. Consulting based in Madrid, with a special focus on the automotive and mobility industry. Matthew is a managing director and partner at L.E.K, Ricardo is the vice president of mobility solutions for Spain and Portugal at Bosch and José is the CEO of the SERNAUTO Spanish Association of Automotive Suppliers.

Cristóbal, Matthew, Ricardo and José are all experts in the automotive and mobility industry, and they have learned that regulation is the key to transitioning to BEVs. Since California’s executive order in 2021, other states have followed suit and OEMs are beginning to invest in developing new BEV models. High prices, low ranges, and a lack of charging infrastructure and supply are all barriers that must be overcome for BEV penetration to increase. With the help of the experts, the U.S. is slowly transitioning to BEVs, with 35% of vehicles sold expected to be BEVs by 2030. The aftermarket will continue to thrive, but with a different set of products and services.

In this episode, you will learn the following:
1. How the U.S. is responding to the shift to BEVs and what regulations are in place to support this transition.
2. How traditional OEMs are adapting to the changing landscape of BEVs and what strategies they are using to capture greater margin and profitability.
3. What opportunities exist for the aftermarket in the transition to BEVs and how different it will look in the future.

Connect with our experts on LinkedIn:
Cristóbal Colón: https://www.linkedin.com/in/cjcolon/
Matthew Wayne: https://www.linkedin.com/in/matthewwayne/
Ricardo Olalla Guerra: https://www.linkedin.com/in/ricardo-olalla-guerra-9b8934b/
José Portilla: https://www.linkedin.com/in/joseportilla/ 

Visit L.E.K. Consulting at https://www.lek.com/

Patients and sites that recruit and enroll patients change how trials are executed. Year after year, R&D costs incurred by biopharmaceutical companies to bring new therapies to the market are skyrocketing.

There is also a lack of appropriate racial representation among study participants. As clinical trial sponsors fail to reach their recruitment targets, these dynamics have led to a greater reliance on clinical trial partnerships for execution.

With this said, in this episode we'll clarify how sites and patients are changing the way trials are executed and how the necessary changes bring growth to the market.

We’re super excited to bring in Matt Wheeler and Ian Tzeng, both Managing Directors in L.E.K. Consulting’s Boston Office, to share their thoughts. They will be today’s speakers.

Connect with our experts on LinkedIn:

Matt Wheeler: https://www.linkedin.com/in/wheelermatthew/

Ian Tzeng: https://www.linkedin.com/in/iantzeng/

Visit L.E.K. Consulting at https://www.lek.com/

This joint strategic outlook by the World Economic Forum and L.E.K. Consulting aims to unite stakeholders across different sectors, industries and geographies to develop and achieve a shared vision for health and healthcare by 2035. 
 
The COVID-19 pandemic created health, economic, political and environmental challenges while exposing global disparities caused by income, age, race, sex and geography, but it also allowed for innovation in science and in medicine development, distribution and delivery. 

We have now reached an opportune time to reflect and embed positive changes from the pandemic response into our global health and healthcare systems moving forward. 

In this episode, we will discuss: 

• What is the vision for health and healthcare by 2035? 
• What are the key issues and barriers to face? 
• What are the solutions to address these issues? 

Adrienne Rivlin and Nivedita Sen will provide their insights while exploring these topics..

Connect with our experts on LinkedIn:

Nivedita Sen: https://www.linkedin.com/in/niveditasen/

Adrienne Rivlin: https://www.linkedin.com/in/adriennerivlin/

Visit L.E.K. Consulting at https://www.lek.com/

In this episode, Claire Davies, Rob Haslehurst and Emile Santos explore the irony of businesses attempting to maintain price increases in an inflationary environment, even as they struggle with the rising costs of labor, logistics and raw materials.
 
"We live in a competitive capitalized economy, and ultimately competitive action is what they're looking for and no business is going to hold prices in a world where competition is driving consumers away from them."

Claire Davies is a Partner in L.E.K. Consulting's Consumer Practice, specializing in the food and beverage, beauty, personal care and direct-to-consumer sectors. Rob Haslehurst is a Partner in L.E.K. Consulting's Consumer Practice, focusing on automotive, home and entertainment, and he specializes in consumer-led growth strategies. Emile Santos is a Partner in L.E.K. Consulting's Consumer Practice, focusing on automotive and mobility as well as consumer health.

Claire Davies, Rob Haslehurst and Emile Santos were discussing the historically high inflation and its impact on businesses and consumers. They found that 90% of businesses were feeling material inflationary impact on their cost of goods sold, labor and raw materials. To offset rising costs, businesses were attempting to pass on price increases or use technology to redesign models and become more efficient while also diversifying their supply chains. Ultimately, their conclusion was that while all businesses feel the impact, their ability to pass on price increases varies by sector and competitive action will determine the outcome.

In this episode, you will learn the following:
1. How consumer businesses are dealing with inflationary pressures and the actions of the Fed to contain inflation.
2. Strategies businesses are using to offset rising costs, such as automation, process redesign and supply diversification.
3. The implications of price increases on consumer behavior and how businesses are responding to maintain consumer loyalty.

Connect with our experts on LinkedIn:
Claire Davies: https://www.linkedin.com/in/claire-davies-00145b8/
Rob Haslehurst: https://www.linkedin.com/in/haslehurst/
Emile Santos: https://www.linkedin.com/in/emile-santos-1820745/ 

Visit L.E.K. Consulting at https://www.lek.com/

In the United States, companies within the manufacturing industry are currently dealing with an unprecedented confluence of challenges. To understand how they’re addressing these challenges and planning for the future, L.E.K. Consulting surveyed some 160 U.S. industrial equipment and technology company executives and conducted in-depth interviews with the most senior survey participants.

In this episode, we invite Eric Navales, Matt Wayne, and Alex Rogalski, all Managing Directors and Partners in L.E.K. Consulting's Boston office, to discuss these challenges and planned strategies.

Connect with our experts on LinkedIn:
Eric Navales: https://www.linkedin.com/in/ericnavales/
Matt Wayne: https://www.linkedin.com/in/matthewwayne/
Alex Rogalski: https://www.linkedin.com/in/alex-rogalski-175a5849/

Visit L.E.K. Consulting at https://www.lek.com/

When you hear the term “Sustainability,” what comes to mind?

Even today, the construction industry continues to thrive. And as the world continues to develop, consumers are becoming more aware of sustainability and, thus, are prioritizing energy-efficient solutions to produce better homes.

However, there is a lot to consider when selecting products and materials to reduce emissions. With that in mind, which materials are the most effective when reducing emissions? And what are companies doing to address sustainability? 

In this episode, we welcome two managing directors to discuss this topic.

Connect with our experts on LinkedIn:
Paul Bromfield: https://www.linkedin.com/in/paulbromfield/
Tim O'Neil:  https://www.linkedin.com/in/tim-oneil-53ba468/

Visit L.E.K. Consulting at https://www.lek.com/

Psychedelics are set to become the next major innovation in mental healthcare. Despite the large flow of investment into this area, the development of psychedelic drugs is not without its hurdles. In this episode, we’ll get an introduction to the challenges surrounding the development of psychedelic drugs for mental healthcare, including clinical trial design, manufacture and commercialization. Participants in this episode are Adrienne Rivlin and Andre Valente, partners in L.E.K. Consulting’s London Office, and guest Tom McDonald, from Clerkenwell Health.

Connect with our experts on LinkedIn:
 Adrienne Rivlin: https://www.linkedin.com/in/adriennerivlin/

Andre Valente: https://www.linkedin.com/in/anvalente/

Tom McDonald: https://www.linkedin.com/in/tom-mcdonald-aba3a318/

Visit L.E.K. Consulting at https://www.lek.com/

Consumers who are concerned about what they are putting into their bodies have similar concerns about what they are putting onto their bodies. In this episode, we are going to take a look at recent food trends that are now converging in the beauty industry.

• The rising importance of product label ingredients
• Specific health attributes
• On-the-go customers value convenience

This episode will explore each of these areas in greater detail, providing examples of how beauty companies are responding. In this episode, we welcome Maria Steingoltz, Alison Schilling, and Anna Ondik to discuss "Illuminating a Path for Beauty".

Connect with our experts on LinkedIn:
Maria Steingoltz: https://www.linkedin.com/in/mariasteingoltz/
Alison Schilling: https://www.linkedin.com/in/alison-schilling/
Anna Ondik: https://www.linkedin.com/in/anna-ondik-464a4b13/

Visit L.E.K. Consulting at https://www.lek.com/